Berjame, Angelita R.

HRN: 17-64-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFTRIAXONE 1G (VIAL)
05/30/2022
06/06/2022
IV
2grams
OD
Infected Wound, Right Foot
Waiting Final Action 

Indication:      Type of Infection:      Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: